Fundraising Fox
Centerline Biomedical
Cleveland, US · Delaware corporation · 3 known investors
Find your way into Centerline Biomedical
Sign up to see every warm intro you have to Centerline Biomedical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Centerline Biomedical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Centerline Biomedical develops IOPS®, a 510(k)-cleared endovascular navigation technology that provides real-time 3D image guidance for physicians performing catheterization and other endovascular procedures. The technology is designed to reduce radiation exposure and improve procedural accuracy for interventional cardiologists, vascular surgeons, and other interventionalists.
Founders & leadership
VG
Vikash GoelFounder · CTO | Operations ♦ Precision Care ♦ Health IT for Minimally Invasive Surgery ♦ Investor RelationsVikash Goel is an engineer who transitioned to executive leadership and currently serves as an executive officer at Centerline Biomedical, where he oversees the development and commercialization of endovascular navigation technology for interventional procedures.
GK
Gulam KhanChief Executive Officer2022–2025Gulam Khan is President and CEO of Centerline Biomedical, which develops IOPS®, a 510(k)-cleared endovascular navigation technology for image-guided catheterization and other interventional procedures. He has extensive experience in medical device executive leadership, including P&L management, strategic planning, new product development, and international market expansion.
IE
Indrani EglestonChief Financial Officer2023–2025Executive Officer at Centerline Biomedical, which develops IOPS®, an endovascular navigation technology for image-guided catheterization and interventional procedures. She has experience in financial analysis and cross-functional project management with executive leadership.
PR
Phil RackliffeChief Executive Officer2019–2022Phil Rackliffe served as President and CEO of Advanced Imaging Solutions at GE HealthCare. He is Executive Officer and Director at Centerline Biomedical, which develops endovascular navigation technology for interventional procedures.
VK
Vinod K. GoelNamed on SEC filing
Board
MW
Michael WhitmanBoard director
TS
Todd SchwarzingerBoard director
MW
Mitch WolfBoard director
AM
Arnaud MarieBoard director
AS
Akhil SaklechaBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$71.8M disclosed across 4 rounds · 2015–2025
▶$10.8MraisedApr 2025 · 8 investors · BiotechnologyRule 506(b)
▶$10.8MraisedApr 2025 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael WhitmanDirector
- Todd SchwarzingerDirector
- Mitch WolfDirector
- Gulam KhanExecutive Officer, Director
- Arnaud MarieDirector
- Indrani EglestonExecutive Officer
- Offering amount
- $15M
- Amount sold
- $10.8M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13.7MraisedNov 2023 · 65 investors · BiotechnologyRule 506(b)
▶$13.7MraisedNov 2023 · 65 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jim ZalarDirector
- Karen ShanahanDirector
- Jai N. GuptaExecutive Officer, Director
- Vinod K. GoelExecutive Officer, Director
- Gulam KhanExecutive Officer
- Vikash GoelExecutive Officer
- Offering amount
- $13.7M
- Amount sold
- $13.7M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.7MraisedNov 2023 · 106 investors · BiotechnologyRule 506(b)
▶$12.7MraisedNov 2023 · 106 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Phil RackliffeExecutive Officer, Director
- Vikash GoelExecutive Officer
- Jai N. GuptaDirector
- Vinod K. GoelExecutive Officer, Director
- Jim ZalarDirector
- Gulam KhanExecutive Officer
- Offering amount
- $12.7M
- Amount sold
- $12.7M
- Sales commissions
- $846.6K
- Placement agents
- Paulson Investment Company, LLC
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$34.7MraisedNov 2023 · 22 investors · BiotechnologyRule 506(b)
▶$34.7MraisedNov 2023 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Vikash GoelExecutive Officer
- Vinod K. GoelExecutive Officer
- Todd SchwarzingerDirector
- Mitch WolfDirector
- Gulam KhanExecutive Officer
- Akhil SaklechaDirector
- Phil RackliffeExecutive Officer, Director
- Offering amount
- $34.7M
- Amount sold
- $34.7M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 6
PlushCarePlushCare is a telehealth service that connects patients with board-certified primary care doctors and therapists through an app for virtual appointments, prescriptions, and ongoing care. It covers weight management, urgent care, pediatric care, chronic disease treatment, online therapy, and prescription discounts, serving patients across all 50 U.S. states.
Honeybee HealthHoneybee Health is a mail-order pharmacy based in California that fills prescription and over-the-counter medications, selling generic drugs at transparent, low prices without insurance. It serves patients directly as well as telehealth platforms and practitioners through a prescription fulfillment partnership program, and can also fill prescriptions for pets.
WalgreensWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
SesameSesame is a telehealth marketplace that connects patients with board-certified providers for cash-pay medical visits without insurance, with prices shown upfront and visits starting at $34. It offers online consultations across a range of care needs through independently owned provider practices using its platform.
DoctronicDoctronic builds an AI system trained on peer-reviewed medical evidence to provide 24/7 medical triage and consultation, achieving 99.2% alignment with board-certified clinicians. The platform serves patients seeking instant healthcare guidance with no insurance requirement, anonymity, and HIPAA compliance.
MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Companies working in the same space as Centerline Biomedical.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $224.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2018 | $223.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Centerline Biomedical do?
- Centerline Biomedical develops IOPS®, a 510(k)-cleared endovascular navigation technology that provides real-time 3D image guidance for physicians performing catheterization and other endovascular procedures. The technology is designed to reduce radiation exposure and improve procedural accuracy for interventional cardiologists, vascular surgeons, and other interventionalists.
- Who founded Centerline Biomedical?
- Centerline Biomedical was founded by Vikash Goel.
- Who are Centerline Biomedical's investors?
- Centerline Biomedical's investors include Device of Tomorrow Capital, JobsOhio Ventures, Jumpstart Ventures.
- How much funding has Centerline Biomedical raised?
- Centerline Biomedical has disclosed $71.8M raised across 4 rounds.
- Where is Centerline Biomedical headquartered?
- Centerline Biomedical is headquartered in Cleveland, US.